Patient Engagement Study to Evaluate the Use of Biological Therapies for Cardiac Arrhythmias

In this patient engagement study, patients and partners will attend a presentation, group meeting and responding to the survey to help the research team gage the acceptability of using a biological therapy to prevent cardiac arrhythmia. Patient Partners will also help to clarify which outcomes are important to patients, to ensure the selected outcomes align with patient interests.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Arrythmia Arrhythmias, Cardiac Behavior Cardiovascular Diseases Health Behavior Heart Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Patient Acceptance of Health Care Patient Participation Treatment Adherence and Compliance

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Ottawa Heart Insitute

Ottawa, Ontario, K1Y4W7, Canada

About this study

There will be four study groups:

Heart patients who experienced a cardiac arrhythmia while in hospital,
Heart patients who did not experience a cardiac arrhythmia while in hospital,
Heart patients with an upcoming procedure that have not had a cardiac arrhythmia,
Members of the general public.

There will be a presentation, two surveys and a team meeting. Results will be compiled and analyzed.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Upcoming or previous cardiac procedure.

Exclusion criteria

Inability to complete an electronic survey or participate in a small group meeting.

Treatment and study plan

Surveys

Other

Surveys to evaluate prior experience, opinions and intervention acceptability.

Focus Group

Other

To answer any questions and discuss topics covered in the standard presentation.

Primary outcomes

Number of participants that would accept a biological therapy for a cardiac arrhythmia as assessed using a survey

Time frame: 2 years

accept a biological therapy

Sponsors and collaborators

Lead sponsor

Ottawa Heart Institute Research Corporation

Other

Registry information

Official study title

Patient Directed Strategies for Cardiac Arrhythmia

Important dates

Study start: 2022
Primary completion: 2023
Study completion: 2023
First posted: Sep 2, 2021
Registry last updated: Apr 9, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed